Workflow guide · Internal intelligence delivery

Route competitor events across functions

Translate one event for clinical, regulatory, commercial, and BD teams.

Biotech Competitive Intelligence TeamsUpdated 2026-07-26Practical workflow

The situation

When this workflow becomes useful

One competitor event carries different implications for clinical, regulatory, commercial, strategy, and BD teams.

Best fit

Competitive intelligence, business development, corporate strategy, clinical, regulatory, and commercial teams inside biotech and pharmaceutical companies.

The challenge

Why the obvious approach breaks down

Translate one event for clinical, regulatory, commercial, and BD teams. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information.

How to think about the task

The reasoning behind the workflow

One competitor event carries different implications for clinical, regulatory, commercial, strategy, and BD teams. For competitive intelligence, the useful response is not simply to collect more links. The task is to decide what the new information changes, which source supports it, who needs to respond, and when the question should be reviewed again.

Translate one event for clinical, regulatory, commercial, and BD teams. The challenge is to preserve the source, define what changed, and connect the update to a decision instead of collecting disconnected information. A repeatable process keeps the work proportional to the decision and creates a record that another investor, analyst, editor, or team member can understand later.

Start with the decision this work must support

“Route competitor events across functions” becomes manageable when the user names the decision before opening more sources. The decision might be whether to escalate an event, update a thesis, change a calendar, commission deeper research, publish a story, or continue monitoring. A defined decision also makes it easier to exclude information that is interesting but not currently useful.

Build a source-linked change record

The core monitoring set for this workflow includes shared source facts, function-specific implication, materiality threshold, recipient and owner, required response. Each material update should retain its source and previous known state. That makes timing changes, accumulating evidence, and repeated execution patterns visible instead of leaving the user with an isolated snapshot.

Turn monitoring into an owned output

A routed intelligence note with one verified fact base and distinct questions or actions for each affected function. The output should state what changed, what remains uncertain, who owns any follow-up, and which future event will resolve the question. The organization shares a common source record while allowing specialists to interpret the event through their own decision needs.

Illustrative example

Illustrative workflow: route competitor events across functions

Begin with the specific company, program, portfolio exposure, audience, or competitive set in scope. Review the highest-confidence source first, compare the disclosure with the previous record, and then use secondary context only where it helps explain the change.

Complete the workflow by producing the defined deliverable rather than ending with a collection of tabs. Assign any unresolved question to an owner and set the next review around the most relevant clinical, regulatory, financial, strategic, or editorial event.

Questions to answer before making a decision

  • What has changed in shared source facts, and why does it matter?
  • What has changed in function-specific implication, and why does it matter?
  • What has changed in materiality threshold, and why does it matter?
  • What has changed in recipient and owner, and why does it matter?
  • What has changed in required response, and why does it matter?

The workflow

A repeatable way to do the work

  1. 01

    Define the specific decision or research question behind “route competitor events across functions.”

  2. 02

    Set the monitored scope around shared source facts and function-specific implication.

  3. 03

    Collect source-linked updates for materiality threshold and record what changed from the prior state.

  4. 04

    Review recipient and owner together with required response before drawing a conclusion.

  5. 05

    Produce the required output, assign follow-up ownership, and set the next review point.

Monitoring checklist

Signals to keep visible

Shared source facts
Function-specific implication
Materiality threshold
Recipient and owner
Required response

Common mistakes

  • Starting the monitoring process without a defined decision question
  • Recording the latest state without preserving its source or previous state
  • Ending with collected information but no owner, conclusion, or next review

Output and outcome

What good looks like

Deliverable

A routed intelligence note with one verified fact base and distinct questions or actions for each affected function.

Practical outcome

The organization shares a common source record while allowing specialists to interpret the event through their own decision needs.

Where BioPharmSignal fits

Reduce the collection work around the decision.

Use LiveFeed and company pages for source-linked monitoring, the PDUFA Calendar for upcoming FDA milestones, and watchlists or alerts to keep the relevant tickers and keywords visible. The workflow still requires independent research and judgment.

Frequently asked questions

Who is this workflow for?

It is designed for biotech competitive intelligence teams and adjacent biotech research users who need a repeatable, source-linked way to complete this task.

What should this workflow produce?

A routed intelligence note with one verified fact base and distinct questions or actions for each affected function.

What is the practical benefit?

The organization shares a common source record while allowing specialists to interpret the event through their own decision needs.